Seroatlas · Human Serome Atlas

S100A9

Protein S100-A9

Also known as: 60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP-14, MRP14, NIF, P14, S100-A9, S10A9_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P06702
Gene
S100A9
Ensembl
ENSG00000163220
Chromosome
1
Canonical length
114 aa
Protein class
Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Subcellular location
Plasma membrane,Intermediate filaments,Cytosol
Secretome location
Secreted to blood
Quaternary structure
Homodimer

OverviewNCBI Gene

The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in the inhibition of casein kinase and altered expression of this protein is associated with the disease cystic fibrosis. This antimicrobial protein exhibits antifungal and antibacterial activity. [provided by RefSeq, Nov 2014]

Canonical amino-acid sequenceUniProt

114 residues, UniProt reviewed canonical sequence.

>P06702|S100A9
     1  MTCKMSQLER NIETIINTFH QYSVKLGHPD TLNQGEFKEL VRKDLQNFLK KENKNEKVIE
    61  HIMEDLDTNA DKQLSFEEFI MLMARLTWAS HEKMHEGDEG PGHHHKPGLG EGTP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against S100A9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
30,401 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 30,401 nTPM
  • esophagus: 30,106 nTPM
  • vagina: 13,777 nTPM
  • cervix: 13,503 nTPM
  • spleen: 5,473 nTPM
  • salivary gland: 5,216 nTPM

Single-cell type

  • esophageal apical cells: 540,719 nCPM
  • esophageal suprabasal cells: 114,171 nCPM
  • neutrophils: 52,381 nCPM
  • neutrophil progenitors: 39,955 nCPM
  • suprabasal keratinocytes: 29,193 nCPM
  • esophageal basal cells: 14,263 nCPM

Immune cell

  • neutrophil: 33,874 nTPM
  • classical monocyte: 24,645 nTPM
  • total PBMC: 24,506 nTPM
  • myeloid DC: 4,681 nTPM
  • eosinophil: 2,635 nTPM
  • intermediate monocyte: 1,759 nTPM

Brain region

  • cerebral cortex: 97 nTPM
  • pons: 26 nTPM
  • medulla oblongata: 23 nTPM
  • choroid plexus: 23 nTPM
  • thalamus: 20 nTPM
  • basal ganglia: 18 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about S100A9.

Disease | ImmuneIEDB

Conditions an epitope on S100A9 was assayed in.

ReferencesPubMed · IEDB

Publications for S100A9 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

1 publication

Reference: B cellIEDB

1 publication

Reference: T cellIEDB

2 publications

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.46
gnomAD pLI
0.48
gnomAD missense Z
0.57
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of S100A9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads S100A9 as an antibody target. Whether an autoantibody or antibody against S100A9 could matter depends on whether native S100A9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

S100A9 is annotated at the cell surface, where native S100A9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label S100A9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/S100A9. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...